Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

PPI triple therapy preferred choice for H. pylori eradication

    • 6 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    PPI triple therapy preferred choice for H. pylori eradication. Pharmacoecon. Outcomes News 109, 5 (1997). https://doi.org/10.1007/BF03271527

    Download citation

    Keywords

    • Omeprazole
    • Metronidazole
    • Clarithromycin
    • Triple Therapy
    • Pylorus Eradication